330 related articles for article (PubMed ID: 15647837)
1. Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
Nagao Y; Kawaguchi T; Ide T; Kumashiro R; Sata M
Int J Mol Med; 2005 Feb; 15(2):237-41. PubMed ID: 15647837
[TBL] [Abstract][Full Text] [Related]
2. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
[TBL] [Abstract][Full Text] [Related]
3. Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy.
Areias J; Velho GC; Cerqueira R; Barbêdo C; Amaral B; Sanches M; Massa A; Saraiva AM
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):825-8. PubMed ID: 8864684
[TBL] [Abstract][Full Text] [Related]
4. Interferon-free therapy with sofosbuvir plus ribavirin for successful treatment of genotype 2 hepatitis C virus with lichen planus: a case report.
Yoshikawa A; Terashita K; Morikawa K; Matsuda S; Yamamura T; Sarashina K; Nakano S; Kobayashi Y; Sogabe S; Takahashi K; Haba S; Oda H; Takahashi T; Miyagishima T; Sakamoto N
Clin J Gastroenterol; 2017 Jun; 10(3):270-273. PubMed ID: 28447325
[TBL] [Abstract][Full Text] [Related]
5. [Association of chronic hepatitis C and lichen planus--in two patients].
Podányi B; Lengyel G; Kiss A; Szakonyi J; Schaff Z; Fehér J
Orv Hetil; 2006 Mar; 147(12):547-50. PubMed ID: 16696378
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and management of oral lichen planus (OLP) with emphasis on the management of hepatitis C virus (HCV)-related OLP.
Mester A; Lucaciu O; Ciobanu L; Apostu D; Ilea A; Campian RS
Bosn J Basic Med Sci; 2018 Aug; 18(3):217-223. PubMed ID: 29984679
[TBL] [Abstract][Full Text] [Related]
7. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C.
Nagao Y; Sata M; Ide T; Suzuki H; Tanikawa K; Itoh K; Kameyama T
Eur J Clin Invest; 1996 Dec; 26(12):1171-4. PubMed ID: 9013095
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study.
Carrozzo M; Gandolfo S; Carbone M; Colombatto P; Broccoletti R; Garzino-Demo P; Ghisetti V
J Oral Pathol Med; 1996 Nov; 25(10):527-33. PubMed ID: 8986963
[TBL] [Abstract][Full Text] [Related]
9. Exacerbation of lichen planus during interferon alfa-2a therapy for chronic active hepatitis C.
Protzer U; Ochsendorf FR; Leopolder-Ochsendorf A; Holtermüller KH
Gastroenterology; 1993 Mar; 104(3):903-5. PubMed ID: 8440441
[TBL] [Abstract][Full Text] [Related]
10. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
11. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
[TBL] [Abstract][Full Text] [Related]
12. Treatment effects and predictors of a 24-week course of interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C.
Tomimatsu M; Aizawa Y; Chuganji Y; Ishizuka H; Fujita Y; Aizawa R; Abe H; Matsuda T; Itou Y; Nakanishi H; Ushiyama H; Higuchi T; Fujimoto T; Endou H; Iga D; Ohta K; Kuroda H
J Gastroenterol Hepatol; 2006 Jul; 21(7):1177-83. PubMed ID: 16824072
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.
Carr C; Hollinger FB; Yoffe B; Wakil A; Phillips J; Bzowej N; Leung J; Mirro K; Poordad F; Moore DH; Gish RG
Liver Int; 2007 Oct; 27(8):1111-8. PubMed ID: 17845540
[TBL] [Abstract][Full Text] [Related]
14. Combination treatment with interferon alfa-2b and ribavirin for chronic hepatitis C in patients who have failed to achieve sustained response to interferon alone: Swedish experience.
Schvarcz R; Ando Y; Sönnerborg A; Weiland O
J Hepatol; 1995; 23 Suppl 2():17-21. PubMed ID: 8720289
[TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation in oral lichen planus with chronic hepatitis C: the role of interferon treatment].
Sugiyama T; Shimizu M; Ohnishi H; Noguchi N; Iwata K; Kojima Y; Watanabe Y; Kawase K; Fukutomi Y; Yamauchi O; Yasuda S; Yamada M; Kobayashi S; Kojima M
Nihon Shokakibyo Gakkai Zasshi; 2000 May; 97(5):568-74. PubMed ID: 10846411
[TBL] [Abstract][Full Text] [Related]
16. Lichen planus associated with hepatitis C virus: no viral transcripts are found in the lichen planus, and effective therapy for hepatitis C virus does not clear lichen planus.
Harden D; Skelton H; Smith KJ
J Am Acad Dermatol; 2003 Nov; 49(5):847-52. PubMed ID: 14576663
[TBL] [Abstract][Full Text] [Related]
17. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
Bizollon T; Ducerf C; Trépo C
J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
[TBL] [Abstract][Full Text] [Related]
18. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group.
Davis GL; Esteban-Mur R; Rustgi V; Hoefs J; Gordon SC; Trepo C; Shiffman ML; Zeuzem S; Craxi A; Ling MH; Albrecht J
N Engl J Med; 1998 Nov; 339(21):1493-9. PubMed ID: 9819447
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of cellular proliferative activity in patients with oral lichen planus and hepatitis C through AgNOR method.
Carli JP; Silva SO; Linden MS; Busin CS; Paranhos LR; Souza PH
Braz Dent J; 2014; 25(6):461-5. PubMed ID: 25590189
[TBL] [Abstract][Full Text] [Related]
20. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
